COMMUNITY OUTREACH AND ENGAGEMENT ? ABSTRACT Karmanos Cancer Institute (KCI) is the largest cancer research and care network in the state of Michigan. Headquartered in the city of Detroit, the KCI catchment area covers 46 of Michigan?s 83 counties, an area that is home to 6.7 million residents. KCI?s mission is to lead in transformative cancer care, research and education through courage, commitment and compassion. Dr. Hayley Thompson (PSDR), Associate Center Director for Community Outreach and Engagement, leads KCI?s efforts in support of this mission. Under her leadership, KCI has expanded its Community Outreach and Engagement (COE) efforts through the Office of Cancer Health Equity and Community Engagement (OCHECE). OCHECE?s activities are guided by a cancer surveillance strategy that captures data across four distinct catchment area regions that are diverse across race, ethnicity, and rurality. Activities are further guided by a participatory research approach in which community stakeholders are actively engaged in research prioritization, implementation, and dissemination. In 2016, OCHECE worked with range of community partners to establish Michigan Cancer HealthLink, a network of Cancer Action Councils (CACs) organized as neighborhood-based and population-driven groups of cancer survivors, caregivers, and advocates who have been historically excluded from meaningful research collaborations. The CAC infrastructure has provided a mechanism for community stakeholders to dialogue with researchers and inform the public relevance of KCI research across the Cancer Center?s four research Programs (Tumor Biology and Microenvironment, Molecular Imaging, Molecular Therapeutics, and Populations Studies and Disparities Research). These strategies of surveillance and engagement ensure that KCI research and outreach are aligned with the cancer burden in the catchment area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088980
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
McKnight, Brooke N; Viola-Villegas, Nerissa T (2018) Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging. Breast Cancer Res 20:130
McFall, Thomas; McKnight, Brooke; Rosati, Rayna et al. (2018) Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. J Biol Chem 293:1163-1177
Dyson, Greg; Farran, Batoul; Bolton, Susan et al. (2018) The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. Am J Cancer Res 8:2088-2095
Greenwald, Mark K; Ruterbusch, Julie J; Beebe-Dimmer, Jennifer L et al. (2018) Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population. Cancer :
An, Mingrui; Wu, Jing; Zhu, Jianhui et al. (2018) Comparison of an Optimized Ultracentrifugation Method versus Size-Exclusion Chromatography for Isolation of Exosomes from Human Serum. J Proteome Res 17:3599-3605
Shah, Seema; Brock, Ethan J; Jackson, Ryan M et al. (2018) Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia 20:951-963
Kariburyo, Furaha; Wang, Yuexi; Cheng, I-Ning Elaine et al. (2018) Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study. BMC Urol 18:55
Yu, Chunsong; An, Myunggi; Jones, Evan et al. (2018) Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity. Pharm Res 35:56
Thakur, Manish K; Heilbrun, Lance; Dobson, Kimberlee et al. (2018) Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 16:e695-e703
Feldmann, Daniel P; Cheng, Yilong; Kandil, Rima et al. (2018) In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells. J Control Release 276:50-58

Showing the most recent 10 out of 826 publications